163 related articles for article (PubMed ID: 30562198)
21. Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [(18)F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience.
Henriksen OM; Larsen VA; Muhic A; Hansen AE; Larsson HBW; Poulsen HS; Law I
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):103-112. PubMed ID: 26363903
[TBL] [Abstract][Full Text] [Related]
22. Value of
Albatly AA; Alsamarah AT; Alhawas A; Veit-Haibach P; Buck A; Stolzmann P; Burger IA; Kollias SS; Huellner MW
Clin Imaging; 2018; 51():68-75. PubMed ID: 29448122
[TBL] [Abstract][Full Text] [Related]
23. The influence of different signal-to-background ratios on spatial resolution and F18-FDG-PET quantification using point spread function and time-of-flight reconstruction.
Rogasch JM; Hofheinz F; Lougovski A; Furth C; Ruf J; Großer OS; Mohnike K; Hass P; Walke M; Amthauer H; Steffen IG
EJNMMI Phys; 2014 Dec; 1(1):12. PubMed ID: 26501454
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI.
Werner JM; Stoffels G; Lichtenstein T; Borggrefe J; Lohmann P; Ceccon G; Shah NJ; Fink GR; Langen KJ; Kabbasch C; Galldiks N
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1889-1901. PubMed ID: 31203420
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET.
Vettermann FJ; Felsberg J; Reifenberger G; Hasselblatt M; Forbrig R; Berding G; la Fougère C; Galldiks N; Schittenhelm J; Weis J; Albert NL; Schüller U
Clin Nucl Med; 2018 Dec; 43(12):895-898. PubMed ID: 30358620
[TBL] [Abstract][Full Text] [Related]
26. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
[TBL] [Abstract][Full Text] [Related]
27.
Suchorska B; Unterrainer M; Biczok A; Sosnova M; Forbrig R; Bartenstein P; Tonn JC; Albert NL; Kreth FW
J Neurooncol; 2018 Sep; 139(3):721-730. PubMed ID: 29948765
[TBL] [Abstract][Full Text] [Related]
28. Validation of MR-Based Attenuation Correction of a Newly Released Whole-Body Simultaneous PET/MR System.
Liu G; Cao T; Hu L; Zheng J; Pang L; Hu P; Gu Y; Shi H
Biomed Res Int; 2019; 2019():8213215. PubMed ID: 31886254
[TBL] [Abstract][Full Text] [Related]
29. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
Rieken S; Habermehl D; Giesel FL; Hoffmann C; Burger U; Rief H; Welzel T; Haberkorn U; Debus J; Combs SE
Radiother Oncol; 2013 Dec; 109(3):487-92. PubMed ID: 23953407
[TBL] [Abstract][Full Text] [Related]
30. Comparison of O-(2-
Verger A; Filss CP; Lohmann P; Stoffels G; Sabel M; Wittsack HJ; Kops ER; Galldiks N; Fink GR; Shah NJ; Langen KJ
World Neurosurg; 2018 May; 113():e727-e737. PubMed ID: 29510293
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
32. Optimization of PET reconstruction algorithm, SUV thresholding algorithm and PET acquisition time in clinical 11C-acetate PET/CT.
Strandberg S; Hashemi A; Axelsson J; Riklund K
PLoS One; 2018; 13(12):e0209169. PubMed ID: 30543705
[TBL] [Abstract][Full Text] [Related]
33. Quantitative biparametric analysis of hybrid
Lohmeier J; Bohner G; Siebert E; Brenner W; Hamm B; Makowski MR
Sci Rep; 2019 Oct; 9(1):14603. PubMed ID: 31601829
[TBL] [Abstract][Full Text] [Related]
34. FET PET in the evaluation of indeterminate brain lesions on MRI: Differentiating glioma from other non-neoplastic causes - A pilot study.
Chan DL; Hsiao E; Schembri G; Bailey DL; Roach PJ; Lee A; Jayamanne D; Ghasemzadeh M; Hayes A; Cook R; Parkinson J; Drummond JP; Ibbett I; Wheeler HR; Back M
J Clin Neurosci; 2018 Dec; 58():130-135. PubMed ID: 30243602
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of 18F-FET PET/CT in newly diagnosed WHO 2016 high-grade glioma.
Dissaux G; Basse V; Schick U; El Kabbaj O; Auberger B; Magro E; Kassoul A; Abgral R; Salaun PY; Bourhis D; Querellou S
Medicine (Baltimore); 2020 Jan; 99(5):e19017. PubMed ID: 32000446
[TBL] [Abstract][Full Text] [Related]
36. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?
Pöpperl G; Kreth FW; Herms J; Koch W; Mehrkens JH; Gildehaus FJ; Kretzschmar HA; Tonn JC; Tatsch K
J Nucl Med; 2006 Mar; 47(3):393-403. PubMed ID: 16513607
[TBL] [Abstract][Full Text] [Related]
37. Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients.
Quak E; Le Roux PY; Hofman MS; Robin P; Bourhis D; Callahan J; Binns D; Desmonts C; Salaun PY; Hicks RJ; Aide N
Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2072-82. PubMed ID: 26219870
[TBL] [Abstract][Full Text] [Related]
38. Impact of point spread function reconstruction on quantitative 18F-FDG-PET/CT imaging parameters and inter-reader reproducibility in solid tumors.
Sheikhbahaei S; Marcus C; Wray R; Rahmim A; Lodge MA; Subramaniam RM
Nucl Med Commun; 2016 Mar; 37(3):288-96. PubMed ID: 26650959
[TBL] [Abstract][Full Text] [Related]
39. Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.
Lasnon C; Desmonts C; Quak E; Gervais R; Do P; Dubos-Arvis C; Aide N
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):985-96. PubMed ID: 23564036
[TBL] [Abstract][Full Text] [Related]
40. Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas.
Blanc-Durand P; Van Der Gucht A; Verger A; Langen KJ; Dunet V; Bloch J; Brouland JP; Nicod-Lalonde M; Schaefer N; Prior JO
PLoS One; 2018; 13(6):e0199379. PubMed ID: 29953478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
